Insider buying last 90 days
No open-market insider purchases were filed for DK in the last 90 days.
From Form 4 filings, dated to when each was filed.
Delek US reported third-quarter 2026 results that exceeded analyst estimates, with revenue of $4.39 billion and diluted EPS of $18.22, alongside net income of $1.13 billion and adjusted EBITDA of approximately $1.28 billion. Management raised its Enterprise Optimization Plan run-rate target to at least $250 million annually, lifted the quarterly dividend by about 18% to $0.30 per share, and outlined roughly $100 million in share repurchases planned for the fourth quarter of 2026. Separate commentary pointed to a further $30 million annual margin opportunity targeted at the El Dorado refinery.
Shares closed at $65.00, up 1.6%, but remain below both the 50-day average of $73.57 is not the case here — price sits between the 50-day average of $73.57 and the 200-day average of $54.15, reflecting a mixed trend. The stock trades in Gekko's Accumulation zone with a GekkoIndex reading of 66.1, and sits 17% below Gekko Fair Value of $78.32.
The next earnings date is 26 February 2027, 103 days away, placing it outside a typical 20-trading-day holding window. Smart-money activity shows one unusual options signal in the last 30 days, with call premium of $417,690 and no put premium recorded. Seasonality data show the next 20 trading days have averaged -6.8% over 5 years, rising in 1 of those years, a factor worth noting alongside the current gap to fair value.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Delek US scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
Averages disagree
Close $68.50 sits between the 50-day ($73.07) and 200-day ($54.91) averages, or the averages disagree.
See the chart59.7, Neutral
Reading 59.7 is in the Neutral zone.
See the GekkoIndex12.4% below
Price is 12.4% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 30 days: 1 unusual options signal.
See smart moneyReports in 103 days
Next report Feb 26, 2027, 103 days away — outside a typical 20-trading-day hold.
See earnings−11.9% on average
From this point in the calendar, the next 20 trading days averaged −11.9% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Delek US closed at $68.50 on Nov 13, 2026, +67.7% over the past year, inside a 52-week range of $25.85 to $82.27.
Use the left and right arrow keys to read daily values.
Put DK on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Delek US turns crude oil into everyday fuels and products for the American market, running a business built around refining, moving, and selling petroleum. It processes raw crude into gasoline, diesel, jet fuel, and asphalt at four refineries in Texas, Arkansas, and Louisiana, supported by three biodiesel plants, and it is also recognized for its network of convenience stores selling fuel and merchandise across West Texas and New Mexico.
The company works through three connected segments. Refining converts crude into finished fuels distributed through its own and outside facilities. Logistics moves and stores crude oil and refined products using pipelines, a gathering network, storage tanks, and distribution terminals, while also marketing fuel for outside parties. Retail runs hundreds of convenience stores under the DK, Alon, and 7-Eleven names, offering fuel alongside food, beverages, tobacco, and general goods. Its customers range from major oil companies and independent refiners to distributors, transportation firms, government buyers, and retail fuel operators.
Delek US was founded in 2001 and is headquartered in Brentwood, Tennessee. Its shares trade on the NYSE under the ticker DK.
Delek US’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.7, in the Neutral zone, down 6.9 points over five sessions.
Down 6.9 points over five sessions, from the Accumulation zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 71 | +1.7% | +1.6% | ||
| Accumulation | 200 | +0.6% | +6.6% | ||
| Neutral (current zone) | 354 | +1.2% | +4.3% | ||
| Distribution | 73 | +0.9% | +1.3% | ||
| Selling | 4 | Too few readings yet | |||
Average DK share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Delek US trades 12.4% below Gekko Fair Value of $78.16, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Delek US shares are worth, recalculated every trading day.
$78.16
Gekko Fair Value, Nov 14, 2026
12.4% Undervalued
At the end of Aug 2026 the price was 17.6% above the estimate.
No open-market insider purchases were filed for Delek US, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for DK in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in DK were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Delek US has been buying back its own shares.
From company filings.
1signal, 100% of the flagged premium in calls.
Latest: Bullish flow on Oct 17, $418K in unusual premium.
1of the funds Gekko tracks holds DK.
Delek US reports on Feb 26, 2027 (103 days away), and beat the EPS estimate in 8 of its last 8 reports.
Feb 26, 2027
103 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $5.48 est $2.21 | $4.09B est $3.44B | −11.3% |
| Apr 29, 2026 | $0.08 est −$1.61 | $2.65B est $2.33B | +13.5% |
| Feb 27, 2026 | $0.44 est −$0.19 | $2.43B est $2.55B | +13.6% |
| Nov 7, 2025 | $1.52 est $0.28 | $2.89B est $2.55B | +5.8% |
| Aug 6, 2025 | −$0.56 est −$0.92 | $2.76B est $2.69B | −1.6% |
| May 7, 2025 | −$2.32 est −$2.43 | $2.64B est $2.76B | +8.8% |
| Feb 25, 2025 | −$2.54 est −$2.82 | $2.37B est $2.69B | −7.7% |
| Nov 6, 2024 | −$1.45 est −$1.61 | $3.04B est $2.48B | +10.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Delek US is $85.79, +25.2% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Mizuho Securities | $80 | +16.8% |
| Nov 11 | Freedom Capital Markets | $88 | +28.5% |
| Nov 10 | Piper Sandler | $90 | +31.4% |
| Nov 10 | Wells Fargo | $95 | +38.7% |
| Nov 9 | Morgan Stanley | $81 | +18.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Delek US averaged −11.9% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −4.8% | 1 of 5 |
| Next 10 trading days | −4.2% | 1 of 5 |
| Next 15 trading days | −9.7% | 0 of 5 |
| Next 20 trading days | −11.9% | 0 of 5 |
| Next 30 trading days | −15.1% | 0 of 5 |
For scale, DK’s typical 20-trading-day move in either direction is about 9.7%.
Delek US’s market cap is $4.15B, with a P/E ratio of 3.6 and revenue of $13.56B over the last twelve months.
Coverage of Delek US this week reads positive: 14 positive, 6 neutral and 0 negative headlines.
Delek US’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MPCMarathon Petroleum | Accumulation | 4.9% below |
| VLOValero Energy | Accumulation | 0.8% above |
| PSXPhillips 66 | Neutral | 7.9% above |
| DINOHF Sinclair | Accumulation | 5.1% above |
| PBFPBF Energy | Accumulation | 14.4% below |
| CVICVR Energy | Accumulation | 1.0% below |
A peer links to its own page where one exists.
Delek US’s market cap is $4.15B at the Nov 13, 2026 close of $68.50, with 60.61M shares outstanding. The shares trade on a P/E ratio of 3.6.
The consensus analyst 12-month price target for Delek US is $85.79, +25.2% from the last close. Of the 10 firms that rated the stock in the last 90 days, 5 rate it a buy, 4 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Delek US is undervalued: the Nov 13, 2026 close of $68.50 is 12.4% below Gekko Fair Value of $78.16. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Delek US is expected to report on Feb 26, 2027 (103 days away). Analysts expect earnings of $5.97 per share on revenue of $3.71B. Delek US beat the earnings estimate in 8 of its last 8 reports, moving 9.1% on average across the report.
Delek US’s 52-week high is $82.27 and its 52-week low is $25.85; it closed at $68.50 on Nov 13, 2026, +67.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (fair value, smart money and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Gekko flagged 1 unusual options signal in Delek US over the last 30 days, with $418K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Oct 17, 2026 with $418K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.